CN112807394A - Medicament for reducing uric acid - Google Patents
Medicament for reducing uric acid Download PDFInfo
- Publication number
- CN112807394A CN112807394A CN201911116306.2A CN201911116306A CN112807394A CN 112807394 A CN112807394 A CN 112807394A CN 201911116306 A CN201911116306 A CN 201911116306A CN 112807394 A CN112807394 A CN 112807394A
- Authority
- CN
- China
- Prior art keywords
- extract
- rice
- uric acid
- medicament
- lily
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 title claims abstract description 24
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 title claims abstract description 20
- 229940116269 uric acid Drugs 0.000 title claims abstract description 20
- 239000003814 drug Substances 0.000 title claims abstract description 17
- 241000209094 Oryza Species 0.000 claims abstract description 23
- 235000007164 Oryza sativa Nutrition 0.000 claims abstract description 23
- 235000009566 rice Nutrition 0.000 claims abstract description 23
- 241000234435 Lilium Species 0.000 claims abstract description 11
- 239000000843 powder Substances 0.000 claims abstract description 10
- 244000077995 Coix lacryma jobi Species 0.000 claims abstract description 9
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 claims abstract description 7
- 238000005303 weighing Methods 0.000 claims abstract description 7
- 238000000227 grinding Methods 0.000 claims abstract description 4
- 238000002156 mixing Methods 0.000 claims abstract description 4
- 229940092385 radish extract Drugs 0.000 claims abstract description 4
- 239000002994 raw material Substances 0.000 claims abstract description 4
- 238000003756 stirring Methods 0.000 claims abstract description 4
- 238000000034 method Methods 0.000 claims abstract description 3
- 210000000582 semen Anatomy 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 230000009261 transgenic effect Effects 0.000 claims description 3
- 244000088415 Raphanus sativus Species 0.000 claims 1
- 229920002472 Starch Polymers 0.000 claims 1
- 235000019698 starch Nutrition 0.000 claims 1
- 239000008107 starch Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 8
- 241000220259 Raphanus Species 0.000 abstract description 6
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 240000005979 Hordeum vulgare Species 0.000 abstract description 2
- 235000007340 Hordeum vulgare Nutrition 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract description 2
- 239000013078 crystal Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- 201000001431 Hyperuricemia Diseases 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 201000005569 Gout Diseases 0.000 description 1
- 206010018634 Gouty Arthritis Diseases 0.000 description 1
- 208000000913 Kidney Calculi Diseases 0.000 description 1
- 206010029148 Nephrolithiasis Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000016097 disease of metabolism Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000000244 kidney pelvis Anatomy 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000005239 tubule Anatomy 0.000 description 1
- 210000000626 ureter Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8994—Coix (Job's tears)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8967—Lilium, e.g. tiger lily or Easter lily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a medicament for reducing uric acid, which comprises the following specific steps: baking the coix seed, the lily, the radish and the rice, grinding the baked coix seed, lily, radish and rice into powder, weighing the coix seed extract, the lily extract, the radish extract and the rice extract with the mass part ratio of 20:50:100:1, mixing, stirring and preparing the medicament. The invention designs a medicament for reducing uric acid, which takes pearl barley, lily, radish and rice as main raw materials, and has good effect of reducing uric acid, small side effect, simple material, low manufacturing cost and good effect in the process of eating by patients.
Description
Technical Field
The invention relates to the technical field of food uric acid reducing medicines, in particular to a medicament for reducing uric acid.
Background
Hyperuricemia is a metabolic disease caused by the fact that a substance called purine is metabolized and disordered in a human body, so that uric acid in blood is increased. The daily production and excretion of uric acid in the body are approximately equal, and in terms of production, one third is from food, two thirds is self-synthesis in the body, and the excretion is from intestinal tract, and two thirds is from kidney. Any of the above routes, if problematic, will cause uric acid elevation. Persistent hyperuricemia can cause other diseases. The highest solubility of uric acid in blood is 420 mu mol/L, and above the value, urate is easy to separate out to form uric acid crystals, and the uric acid crystals are deposited on tissues and cause inflammatory diseases, such as joint deposition, so as to cause the well-known gouty arthritis; urate crystals deposit on renal pelvis, ureter or renal tubule and renal interstitium, causing renal damage and causing renal calculus; the existing uric acid-reducing drugs have side effects, so a uric acid-reducing drug is provided.
Disclosure of Invention
The present invention aims at providing one kind of medicine for lowering uric acid to solve the problems of the background technology.
In order to achieve the purpose, the invention provides the following technical scheme: an agent for reducing uric acid, comprising the steps of:
a. weighing coix seeds, lily, radishes and rice with the mass part ratio of 20:50:100: 1;
b. baking Coicis semen, Bulbus Lilii, radix Raphani and rice respectively, and grinding into powder to obtain Coicis semen powder extract, Bulbus Lilii extract, radix Raphani extract and rice extract;
c. weighing the coix seed powder extract, the lily extract, the radish extract and the rice extract with the mass part ratio of 20:50:100:1, mixing, stirring and preparing the medicament.
Preferably, the rice is prepared from non-transgenic rice.
Compared with the prior art, the invention has the beneficial effects that: the invention designs a medicament for reducing uric acid, which takes pearl barley, lily, radish and rice as main raw materials, and has good effect of reducing uric acid, small side effect, simple material, low manufacturing cost and good effect in the process of eating by patients.
Detailed Description
The invention will be further described with reference to specific examples, but the scope of the invention is not limited thereto.
The present invention provides a first embodiment: an agent for reducing uric acid, comprising the steps of:
a. weighing coix seeds, lily, radishes and rice with the mass part ratio of 20:50:100: 1;
b. baking Coicis semen, Bulbus Lilii, radix Raphani and rice respectively, and grinding into powder to obtain Coicis semen powder extract, Bulbus Lilii extract, radix Raphani extract and rice extract;
c. weighing the coix seed powder extract, the lily extract, the radish extract and the rice extract with the mass part ratio of 20:50:100:1, mixing, stirring and preparing the medicament.
Specifically, the rice takes non-transgenic rice as a raw material.
When in use, 10g of the medicament is taken with hot water, three times a day, after being taken after a meal, the medicament takes effect for three days, and the uric acid can be reduced by 30-40 mol for two days after the medicament is taken.
The above description is only for the preferred embodiment of the present invention, but the scope of the present invention is not limited thereto, and any person skilled in the art should be considered to be within the technical scope of the present invention, and the technical solutions and the inventive concepts thereof according to the present invention should be equivalent or changed within the scope of the present invention.
Claims (2)
1. An agent for reducing uric acid, comprising:
a. weighing coix seeds, lily, radishes and rice with the mass part ratio of 20:50:100: 1;
b. baking Coicis semen, Bulbus Lilii, radix Raphani and rice respectively, and grinding into powder to obtain Coicis semen powder extract, Bulbus Lilii extract, radix Raphani extract and rice extract;
c. weighing the coix seed powder extract, the lily extract, the radish extract and the rice extract with the mass part ratio of 20:50:100:1, mixing, stirring and preparing the medicament.
2. The method of preparing acorn starch of claim 1, wherein: the rice takes non-transgenic rice as a raw material.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911116306.2A CN112807394A (en) | 2019-11-15 | 2019-11-15 | Medicament for reducing uric acid |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911116306.2A CN112807394A (en) | 2019-11-15 | 2019-11-15 | Medicament for reducing uric acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112807394A true CN112807394A (en) | 2021-05-18 |
Family
ID=75851389
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201911116306.2A Pending CN112807394A (en) | 2019-11-15 | 2019-11-15 | Medicament for reducing uric acid |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112807394A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117414401A (en) * | 2023-12-15 | 2024-01-19 | 西北农林科技大学深圳研究院 | Composition for relieving hyperuricemia and preparation method thereof |
-
2019
- 2019-11-15 CN CN201911116306.2A patent/CN112807394A/en active Pending
Non-Patent Citations (1)
| Title |
|---|
| 医道无涯: "百合、薏米是治痛风的绝妙搭配！现在就告诉你怎么用", pages 1 - 2, Retrieved from the Internet <URL:http://www.360doc.com/content/16/0526/12/17543744_562426464.shtml> * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117414401A (en) * | 2023-12-15 | 2024-01-19 | 西北农林科技大学深圳研究院 | Composition for relieving hyperuricemia and preparation method thereof |
| CN117414401B (en) * | 2023-12-15 | 2024-04-26 | 西北农林科技大学 | Composition for relieving hyperuricemia and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106420643B (en) | A kind of chewable tablets and preparation method thereof containing vitamine C sodium | |
| US20080171103A1 (en) | Healthy And Functional Foods For The Obesity Patients Using Purple-Colored Potato | |
| CN103705525B (en) | A kind of medicine containing limonin treatment ulcerative colitis and its preparation method and application | |
| CN112807394A (en) | Medicament for reducing uric acid | |
| CN103494794A (en) | Medical application of bibenzyl compounds | |
| CN107580496A (en) | The anti-glycosuria effect of gypenoside 75 | |
| CN101843814A (en) | Chinese medicinal compound preparation for treating gout and hyperuricemia and preparation method thereof | |
| CN106619624B (en) | Application of epalrestat in preparing medicine for treating hyperuricemia and gout | |
| CN111407773A (en) | Natural biological anti-inflammatory antibacterial agent | |
| CN108578419B (en) | A kind of hypoglycemic medicine composition of ginsenoside Rg1 and melbine | |
| CN103735550B (en) | A kind of pharmaceutical composition and application thereof for the treatment of chronic kidney disease myocardial damage | |
| CN109381465A (en) | Wo Nuolazan is preparing the application in antigout preparation | |
| CN101530405B (en) | Citric acid and compound citric acid application in pharmacy | |
| WO2021043196A1 (en) | Use of 5-methyltetrahydrofolate | |
| CN113855689A (en) | Application of engeletin or isomer thereof in preparation of medicine for treating endometriosis | |
| CN100571704C (en) | Fixed dosage antitubercular agent compound pharmaceutical and preparation method thereof | |
| CN111375002A (en) | Pharmaceutical composition for treating hyperuricemia and preparation method and application thereof | |
| CN117045709B (en) | Method for preventing and treating calculus by using Polygonum capitatum extract | |
| CN102302780A (en) | Pharmaceutical composition for treating bronchial asthma | |
| CN103961654B (en) | A kind of White staphylococcus sheet and preparation method thereof | |
| CN115381908A (en) | Traditional Chinese medicine composition for treating vaginitis and traditional Chinese medicine preparation containing traditional Chinese medicine composition | |
| CN111789842B (en) | Application of nintedanib in preparation of medicine for treating inflammatory bowel disease | |
| CN102283832B (en) | Medicinal composition for preventing or treating hypertensive obese patient and application thereof | |
| CN102631355B (en) | Medicine composite containing aspirin and application thereof | |
| KR20120048250A (en) | Anti-inflammatory composition containing thiourea compound or pharmaceutically acceptable salts thereof as active ingredient |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20210518 |
|
| WD01 | Invention patent application deemed withdrawn after publication |